Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Dec;36(12):2804–2807. doi: 10.1128/aac.36.12.2804

Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery.

C Martin 1, J Ragni 1, F Lokiec 1, J C Guillen 1, A Auge 1, M Pecking 1, F Gouin 1
PMCID: PMC245549  PMID: 1482149

Abstract

The pharmacokinetics and tissue penetration of ceftriaxone after a single intravenous injection of 1,000 mg to 17 patients for antibiotic prophylaxis in thoracic surgery were studied. The patients were scheduled for elective noncardiac thoracic surgery. Adequate levels in serum (higher than or equal to the MIC for 90% of isolates of Staphylococcus aureus, Streptococcus spp., Escherichia coli, Haemophilus influenzae, and Klebsiella pneumoniae) were found for all patients throughout the surgical procedures. Mean maximal (5-min) and final (24-h) ceftriaxone levels in serum were 157 +/- 42 and 8.6 +/- 4.5 mg/liter, respectively. The beta-phase elimination half-life was 8.6 +/- 3 h, the plasma clearance was 18.4 +/- 6.25 ml/min, and the apparent volume of distribution at steady state was 0.21 +/- 0.07 liters/kg. At the time of the thoracotomy, the ceftriaxone concentrations were 13.5 +/- 7.8 micrograms/g in thoracic wall fat and 27 +/- 9 micrograms/g in lung tissue. At the time of closure, the ceftriaxone concentration was 15 +/- 9 micrograms/g in thoracic wall fat. During the different steps of the surgical procedures, 100% of patients had adequate levels in tissue (higher than or equal to the MIC for 90% of isolates of Streptococcus spp., E. coli, H. influenzae, and K. pneumoniae). For S. aureus, 90 to 100% of patients had adequate tissue ceftriaxone levels.

Full text

PDF
2804

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergamini T. M., Polk H. C., Jr The importance of tissue antibiotic activity in the prevention of operative wound infection. J Antimicrob Chemother. 1989 Mar;23(3):301–313. doi: 10.1093/jac/23.3.301. [DOI] [PubMed] [Google Scholar]
  2. Brogden R. N., Ward A. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. Drugs. 1988 Jun;35(6):604–645. doi: 10.2165/00003495-198835060-00002. [DOI] [PubMed] [Google Scholar]
  3. Conte J. E., Jr, Cohen S. N., Roe B. B., Elashoff R. M. Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens. Ann Intern Med. 1972 Jun;76(6):943–949. doi: 10.7326/0003-4819-76-6-943. [DOI] [PubMed] [Google Scholar]
  4. DiPiro J. T., Cheung R. P., Bowden T. A., Jr, Mansberger J. A. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg. 1986 Nov;152(5):552–559. doi: 10.1016/0002-9610(86)90228-x. [DOI] [PubMed] [Google Scholar]
  5. Frimodt-Møller N., Ostri P., Pedersen I. K., Poulsen S. R. Antibiotic prophylaxis in pulmonary surgery: a double-blind study of penicillin versus placebo. Ann Surg. 1982 Apr;195(4):444–450. doi: 10.1097/00000658-198204000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ilves R., Cooper J. D., Todd T. R., Pearson F. G. Prospective, randomized, double-blind study using prophylactic cephalothin for major, elective, general thoracic operations. J Thorac Cardiovasc Surg. 1981 Jun;81(6):813–817. [PubMed] [Google Scholar]
  7. Kaiser A. B. Antimicrobial prophylaxis in surgery. N Engl J Med. 1986 Oct 30;315(18):1129–1138. doi: 10.1056/NEJM198610303151805. [DOI] [PubMed] [Google Scholar]
  8. Knapp C. C., Sierra-Madero J., Washington J. A. Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone. Antimicrob Agents Chemother. 1988 Dec;32(12):1896–1898. doi: 10.1128/aac.32.12.1896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kosmidis J., Stathakis C., Mantopoulos K., Pouriezi T., Papathanassiou B., Daikos G. K. Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid. J Antimicrob Chemother. 1980 Sep;6 (Suppl A):147–151. doi: 10.1093/jac/6.suppl_a.147. [DOI] [PubMed] [Google Scholar]
  10. Kvale P. A., Ranga V., Kopacz M., Cox F., Magilligan D. J., Davila J. C. Pulmonary resection. South Med J. 1977 Oct;70 (Suppl 1):64–68. doi: 10.1097/00007611-197710001-00018. [DOI] [PubMed] [Google Scholar]
  11. Lorian V. Low concentrations of antibiotics. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):15–26. doi: 10.1093/jac/15.suppl_a.15. [DOI] [PubMed] [Google Scholar]
  12. Mutch D., Richards G., Brown R. A., Mulder D. S. Bioactive antibiotic levels in the human aorta. Surgery. 1982 Dec;92(6):1068–1071. [PubMed] [Google Scholar]
  13. Patel I. H., Kaplan S. A. Pharmacokinetic profile of ceftriaxone in man. Am J Med. 1984 Oct 19;77(4C):17–25. [PubMed] [Google Scholar]
  14. Pitt H. A., Roberts R. B., Johnson W. D., Jr Gentamicin levels in the human biliary tract. J Infect Dis. 1973 Mar;127(3):299–302. doi: 10.1093/infdis/127.3.299. [DOI] [PubMed] [Google Scholar]
  15. Pollock A. A., Tee P. E., Patel I. H., Spicehandler J., Simberkoff M. S., Rahal J. J., Jr Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults. Antimicrob Agents Chemother. 1982 Nov;22(5):816–823. doi: 10.1128/aac.22.5.816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Roncoroni A. J., Manuel C., Nedjar C., Bauchet J., Mariani D. Cefamandole bone diffusion in patients undergoing total hip replacement. Chemotherapy. 1981;27(3):166–172. doi: 10.1159/000237973. [DOI] [PubMed] [Google Scholar]
  17. Stone H. H. Basic principles in the use of prophylactic antibiotics. J Antimicrob Chemother. 1984 Sep;14 (Suppl B):33–37. doi: 10.1093/jac/14.suppl_b.33. [DOI] [PubMed] [Google Scholar]
  18. Washington J. A., 2nd The effects and significance of subminimal inhibitory concentrations of antibiotics. Rev Infect Dis. 1979 Sep-Oct;1(5):781–786. doi: 10.1093/clinids/1.5.781. [DOI] [PubMed] [Google Scholar]
  19. Zak O., Kradolfer F. Effects of subminimal inhibitory concentrations of antibiotics in experimental infections. Rev Infect Dis. 1979 Sep-Oct;1(5):862–879. doi: 10.1093/clinids/1.5.862. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES